Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

As new therapies and modalities are emerging for treating head and neck cancers, Cleveland Clinic Cancer Center is hosting an in-person CME program highlighting:

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

  • Emerging surgical techniques
  • Radiation and chemotherapy best practices
  • Recognizing and diagnosing rare head and neck cancers
  • The necessity for multidisciplinary care
  • Managing referral decisions

“The course will highlight innovative approaches to head and neck cancer treatment,” says Joseph Scharpf, MD, Director of Head and Neck Endocrine Surgery at Cleveland Clinic. “It will provide an excellent contemporary update and highlight cutting-edge treatments, which have evolved in all the specialties represented.”

The program, entitled 2023 Contemporary Multidisciplinary Care of the Head and Neck Cancer Patient: Updates on the Innovative Approaches to Head and Neck Cancer Treatment, will be held on Friday, November 17, 2023 at Cleveland Clinic Learner Research Institute. The sessions are recommended for head and neck surgeons, otolaryngologists, medical oncologists, radiation oncologists, trainees, advanced practice providers as well as speech language pathologists and nurses involved in the diagnosis and treatment of head and neck cancers.

Specialists from head and neck oncology, head and neck endocrine surgery, radiation oncology, medical oncology, speech and language pathology, oral rehabilitation surgery, dermatologic surgery, radiology, pathology and reconstructive surgery will lead the sessions. “The panels include expert faculty drawing from leaders in our field internally at Cleveland Clinic and nationally recognized guests, including an alumnus as a guest of honor,” says Dr. Scharpf.

Advertising Policy

Program highlights

Sessions will cover:

  • Advances in screening and prevention of head and neck cancer
  • Utilization of molecular and nonmolecular biomarkers in treatment decisions
  • Recent innovations in treating advanced cutaneous squamous cell carcinoma
  • Innovative approaches to improving functional and quality of life outcomes
  • Tumor board cases

CME credits

This live activity represents a maximum of 7.50 AM PRA category 1 credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for category 2 credit. A certificate of participation will be provided to other health care professionals for requesting credit in accordance with their professional boards and/or associations.

Session fee

$150 for physicians
$50 for allied health professionals, residents and fellows

Advertising Policy

Register now.